ITGR — Integer Holdings Corporation stock price, charts and financials

QT75Integer Holdings Corporation

Integer Holdings Corporation (NYSE: ITGR) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
124.45
+3.24+2.67%
ITGRQT75Integer Holdings Corporation·NYSE
124.45+2.67%
News
Up 2.7% — $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Integer Holdings Corporation (NYSE: ITGR) (prnewswire.com).
Medium confidence
TA
Loading chart...
Screen all →
Snapshot
Index-P/E29.85EPS (ttm)4.06Insider Own2.60%Shs Outstand33.95MPerf Week22.91%
Market Cap4.12BForward P/E17.78EPS next Y6.82Insider Trans-0.09%Shs Float33.46MPerf Month28.17%
Enterprise Value5.49BPEG0.39EPS next Q-Inst Own-Short Float13.01%Perf Quarter36.94%
Income140.34MP/S2.22EPS this Y51.73%Inst Trans-Short Ratio8.10Perf Half Y40.18%
Sales1.85BP/B2.45EPS next Y12.08%ROA4.16%Short Interest4.35MPerf YTD54.55%
Book/sh-P/C21.92EPS next 5Y10.77%ROE8.23%52W High126.80 -1.85%Perf Year11.45%
Cash/sh-P/FCF41.24EPS past 3/5Y13.82% 4.40%ROIC5.35%52W Low63.66 95.50%Perf 3Y39.34%
Dividend Est.-EV/EBITDA16.50Sales past 3/5Y11.52% 11.46%Gross Margin23.31%Volatility6.86% 3.80%Perf 5Y31.85%
Dividend TTM-EV/Sales2.97EPS Y/Y TTM17.94%Oper. Margin10.41%ATR (14)4.20Perf 10Y278.78%
Dividend Ex-Date-Quick Ratio2.38Sales Y/Y TTM7.80%Profit Margin7.67%RSI (14)83.47Recom2.20
Dividend Gr. 3/5Y-Current Ratio3.75EPS Q/Q-8.40%SMA2024.37%Beta0.61Target Price107.50
Payout0.00%Debt/Eq0.81Sales Q/Q0.92%SMA5029.22%Rel Volume4.91Prev Close121.21
Employees11,000LT Debt/Eq0.79EarningsAug 06SMA20042.57%Avg Volume531.53KPrice124.45
IPO DateSep 29, 2000Option/ShortYes / YesEPS/Sales Surpr.1.25% 3.07%Net Debt/EBITDA4.13Volume2,608,095Change2.67%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-21-26ReiteratedKeyBancOverweight$133$104
Jul-16-26ReiteratedTruist SecuritiesBuy$95$110
May-13-26UpgradeOppenheimerPerformOutperform$115
Feb-23-26ReiteratedRaymond JamesOutperform$95$101
Feb-20-26UpgradeBenchmarkHoldBuy
Dec-18-25ReiteratedTruist SecuritiesBuy$86$95
Nov-24-25ReiteratedTruist SecuritiesBuy$88$86
Oct-24-25DowngradeCitigroupBuyNeutral
Oct-24-25ReiteratedPiper SandlerOverweight$82
Oct-24-25ReiteratedRaymond JamesOutperform$95
Latest News
Today
Jul-31-26
Jul-30-26
Jul-25-26
Jul-23-26
Jul-16-26
Jul-08-26
Company

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,8511,8461,7171,5561,3311,2211,0731,2581,215
Cost of Goods Sold Incl. D&A1,4191,4211,2551,144985884788903852
Gross Profit431426461412347337286355363
Selling, General and Administrative Excl. Other177163184171157142137139142
Research and Development514653626052484749
Other Operating Expense1181615177-201116
Operating Income193209208163113136121158156
Interest Expense384256533732385399
Unusual Expense
Non-Operating Income (Expense)5-42-4-5-7-3405
Net Income Before Taxes159125148105691018610561
Income Taxes172327169891414
Consolidated Net Income1431031209166977796168
Net Income From Continuing Operations143103121896093779147
Net Income1431031209166977796168
EPS (Recurring)4.062.963.602.721.972.822.352.805.23
EPS (Basic, Before Extraordinaries)4.062.963.602.721.972.822.352.805.23
EPS (Diluted)4.012.893.402.691.962.802.332.775.15
EBITDA333294333276222225183247253
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio31.0327.1438.9836.8334.9330.5734.8529.0414.81
Price To Sales Ratio2.291.492.622.101.702.312.502.112.01
Gross Margin23.2823.0826.8526.4826.0727.6026.6528.2229.88
Operating Margin10.4311.3212.1110.488.4911.1411.2812.5612.84
Net Margin7.735.586.995.854.967.947.187.6313.83
Shares Outstanding343534333333333332
Market Capitalization4,2312,7454,5063,2702,2592,8242,6792,6542,440
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$133.62$113.75$93.89$74.02$54.15 Close Price0.00K74.30K148.59K222.89K297.19KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Thor Kirk KChief Human Resources OfficerJun 30 '26Option Exercise0.006,120041,102Jul 01
Stephens JimPresident, CRM & NeuroMay 15 '26Option Exercise0.001,96306,331May 19
Smith DironEVP, Chief Financial OfficerMay 08 '26Option Exercise0.002,063013,422May 12
Harris John AEVP, Global Ops and ManufacturMar 31 '26Option Exercise0.003,837010,499Apr 02
Blackwood Lindsay K.SVP, Gen Counsel & SecretaryMar 24 '26Option Exercise0.003,48303,483Mar 25
Carr TerenceEVP, Qlty & Regulatory AffairsMar 24 '26Option Exercise0.001,35001,350Mar 25
Thomas Tommy PVP, Corporate ControllerMar 13 '26Sale85.0082570,1254,381Mar 17
Khales PaymanPresident & CEOFeb 24 '26Option Exercise0.0043,060078,799Feb 24
Thomas Tommy PVP, Corporate ControllerJan 20 '26Option Exercise0.0033704,391Jan 21
Smith DironEVP, Chief Financial OfficerJan 20 '26Option Exercise0.00292011,058Jan 21
Thor Kirk KChief Human Resources OfficerJan 20 '26Option Exercise0.00816028,750Jan 21
Senn AndrewSVP, Strategy and Business DevJan 20 '26Option Exercise0.002,224012,625Jan 21
Khales PaymanPresident & CEOJan 20 '26Option Exercise0.001,348026,434Jan 21
Smith DironEVP, Chief Financial OfficerJan 19 '26Option Exercise0.001,709010,766Jan 21
Stephens JimPresident, CRM & NeuroJan 19 '26Option Exercise0.0075802,032Jan 21
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.